Results 111 to 120 of about 990 (149)

Distinct decrease in peripheral lymphocytes in EBER-positive cases of MTX-LPD

Modern Rheumatology, 2021
Masahiro Kondo, Keiichi Onoda, Mayuko Moriyama   +2 more
exaly  

Lean in the construction phase of the LPDS

2020
Lincoln H. Forbes, Syed M. Ahmed
openaire   +1 more source

Multi-antigen vaccination with LPD nanoparticles containing rgp63 and rLmaC1N proteins induced effective immune response against leishmaniasis in animal model

Journal of Drug Delivery Science and Technology, 2021
Parvin Zamani, Fereidoun Mahboudi, Seyedeh Hoda Alavizadeh   +2 more
exaly  

Intracerebral manifestation of iatrogenic, immunodeficiency-associated polymorphic B-LPD with morphology mimicking Hodgkin lymphoma: a case report and literature review

Journal of Hematopathology, 2022
Leonie Saft, Georgios Rassidakis
exaly  

LPD

2006
openaire   +1 more source

LPD Nanoparticles for Gene Delivery

Nature Biotechnology, 1999
openaire   +1 more source

Proposed categorization of pathological states of EBV‐associated T/natural killer‐cell lymphoproliferative disorder (LPD) in children and young adults: Overlap with chronic active EBV infection and infantile fulminant EBV T‐LPD

Pathology International, 2008
Hiroshi Kimura
exaly  

Targeting of Lipid-Protamine-DNA (LPD) Lipopolyplexes Using RGD Motifs

Journal of Liposome Research, 2003
Pierrôt Harvie, Pervin Anklesaria
exaly  

The LPD Effect

2016
openaire   +1 more source

TRANSFER OF SKILLS IN THE LPD

2000
openaire   +1 more source